MorphoWave™ Compact by IDEMIA: New Compact, Frictionless Access Control Terminal Unveiled at ISC West
IDEMIA, the global leader in Augmented Identity, announces today the launch of MorphoWave™ Compact, the newest addition to its range of products for frictionless biometric access control. This masterpiece of engineering relies on IDEMIA’s patented, touchless 3D fingerprint technology: it delivers the field-proven performance of the award-wining MorphoWave Tower in a stylish and compact reader, designed for wall-mounted access control and time & attendance applications.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180411005345/en/
MorphoWave Compact is 86% smaller than MorphoWave Tower, while retaining the same large scanning volume. It acquires four fingers in 3D for maximum accuracy, with one pass of the hand over the sensor. The ergonomic touchless operation delivers an unmatched combination of security, convenience and throughput. MorphoWave Compact’s reduced size comes with a very competitive cost of ownership, an IP65 rating and a rich feature set to ensure that users can now experience frictionless access everywhere…with a simple wave of the hand.
As the global leader in fingerprint technology for more than four decades, IDEMIA has served the world’s largest users of biometrics. Over the past ten years, IDEMIA has combined tremendous R&D efforts with large-scale, high volume deployments of touchless fingerprint technology, to ensure that frictionless biometric access is a proven reality today.
“The overwhelming success of our MorphoWave Tower in major Fortune 500 companies across the globe – such as, so far, corporate headquarters, large manufacturing sites, prestigious universities, and some of the largest banks and financial institutions around the globe – not only proves the technology delivers on its promise, but also confirms the potential and hunger to use it everywhere,” said Philippe Barreau, Executive Vice-President of Citizen Identity and Public Security activities at IDEMIA. “We have designed MorphoWave Compact specifically with this in mind, to allow customers to leverage the technology beyond the lobby, at every door.”
Visitors to the ISC West exhibition in Las Vegas (April 11 – 13, 2018) have the opportunity to discover MorphoWave Compact at booth #4071
OT-Morpho is now IDEMIA, the global leader in Augmented Identity for an increasingly digital world, with the ambition to empower citizens and consumers alike to interact, pay, connect, travel and vote in ways that are now possible in a connected environment.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, we reinvent the way we think, produce, use and protect this asset, whether for individuals or for objects. We ensure privacy and trust as well as guarantee secure, authenticated and verifiable transactions for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
With over $3 billion in revenues, IDEMIA is the result of the coming together of OT (Oberthur Technologies) and Safran Identity & Security (Morpho). With 14,000 employees around the world, IDEMIA serves clients in over 180 countries.
For more information, head to www.idemia.com . And follow us @IdemiaGroup on Twitter
Havas Paris PR Agency
Hanna SEBBAH, +33 (0) 6 63 73 30 30
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
FL-MLB22.9.2018 00:15 | pressemeddelelse
American Airlines Announces Nonstop Philadelphia (PHL) to Orlando Melbourne (MLB)
NY-BCW/PALLADINO21.9.2018 19:45 | pressemeddelelse
Amy Palladino Joins BCW as Executive Vice President, Managing Director, Corporate Practice
HEIDELBERG-ENGINEERING21.9.2018 18:43 | pressemeddelelse
Heidelberg Engineering Announces the CE-Marking of ANTERION
JEDOX21.9.2018 17:48 | pressemeddelelse
Florian Winterstein Becomes New CEO of Jedox
AVINOR21.9.2018 16:39 | pressemeddelelse
Avinor to Test Autonomous Snowploughs at Oslo Airport This Winter
MA-TAKEDA-PHARMACEUTICAL21.9.2018 15:32 | pressemeddelelse
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum